BMC Cancer

Table 1 Association of miR-1275 expression with the clinicopathological characteristics of GC

From: MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1

Variable	Category	Relative miR-1275 expression		χ2	p
Variable	Category	Low (69)	High (51)	χ2	p
Age	< 60	18	18	1.184	0.277
Age	≥60	51	33	1.184	0.277
Sex	Male	30	22	0.001	0.970
Sex	Female	39	29	0.001	0.970
Tumor location	Upper stomach	5	0	6.092	0.107
	Middle stomach	20	10
	Lower stomach	40	36
	Mixed	4	5
Borrmann type	*Early stage*	20	0	*23.213*	*< 0.001*
	*I + II type*	20	10
	*III + IV type*	29	41
Histological differentiation	Well	10	5	0.610	0.737
	Moderate	21	17
	Poor	38	29
Tumor invasion(AJCC)	*Tis-T*₂	40	10	*17.757*	*< 0.001*
Tumor invasion(AJCC)	T₃-T₄	29	41	*17.757*	*< 0.001*
Lymph node metastasis	*Yes*	31	48	*31.546*	*< 0.001*
Lymph node metastasis	No	38	3	*31.546*	*< 0.001*
TNM stage(AJCC)	*I-II*	39	10	*16.540*	*< 0.001*
TNM stage(AJCC)	*III-IV*	30	41	*16.540*	*< 0.001*

Bold values are significant, P < 0.05

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com